Blood pressure drug recalled after carcinogenic substance found

A biotech company has recalled its high blood pressure drug after finding that several batches of the medication contained a potentially cancer-causing substance, Taiwan's Food and Drug Administration (FDA) said Saturday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)